Aschenbrenner, Laura

4Covance, Inc., Early Phase Development Solutions, Madison, Wisconsin.

1 paper on CoChat

Most cited papers

Verified
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
Panowski, S. H., Kuo, T. C., Zhang, Y., Chen, A., Geng, T., Aschenbrenner, L., Kamperschroer, C., Pascua, E., Chen, W., Delaria, K., et al. (2019) · Molecular Cancer Therapeutics
Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
Cited by 48

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free